Websites and locations

Arkema has set up a system to monitor the list of SVHCs defined under REACH and used in its production or placed on the market. With REACH, Europe has introduced a two-stage authorization procedure:
 

  • the first consists in identifying substances that could have potential serious repercussions on human health or the environment. Once identified as such, they are added to the list of candidate substances for authorization (Annex XIV); and

     

 

  • the second phase is to ensure that the risks posed by substances of very high concern are adequately controlled, and that these substances are progressively replaced by appropriate alternatives. These substances may not be placed on the market or used after a given date, unless authorization is granted for their specific use or their use is exempted from authorization.
Top